Acute myocardial infarction and proinflammatory gene variants

Annals of the New York Academy of Sciences

Volumn 1119, Issue 1, 2007, Pages 227-242

  Licastro, Federico ^a   Chiapelli, Martina ^a   Caldarera, Claudio Marcello ^b   Caruso, Calogero ^c   Lio, Domenico ^c   Corder, Elizabeth H ^d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Istituto Nazionale Per le Ricerche Cardiovascolari (INRC)   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d DUKE UNIVERSITY   (United States)

Author keywords

Acute myocardial infarction; Apolipoprotein E; Cholesterol; Gene variants; Grade of membership analysis; Inflammation

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; GAMMA INTERFERON; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INTERLEUKIN 10; INTERLEUKIN 6; SERINE PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR;

ACUTE HEART INFARCTION; ADULT; AGED; ALLELE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; PATHOGENESIS;

EID: 36549017648     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1404.004     Document Type: Conference Paper

References (62)

1. BRAUNWALD, E. 1997. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N. Engl. J. Med. 337: 1360-1369.
2. WEIR, R.A., J.J. MCMURRAY & E.J. VELAZQUEZ. 2006. Epidemiology of heart failure and left ventricular systolic dysfunction after acutemyocardial infarction: prevalence, clinical characteristics, and prognostic importance. Am. J. Cardiol. 97: 13F-25F.
3. GUPTA, R. & S. KAUFMAN. 2006. Cardiovascular emergencies in the elderly. Emerg. Med. Clin. North Am. 24: 339-370.
4. CUMMINGS, D.M., D.E. KING, A.G. MAINOUS & M.E. GEESEY. 2006. Combining serum biomarkers: the association of C-reactive protein, insulin sensitivity, and homocysteine with cardiovascular disease history in the general US population. Eur. J. Cardiovasc. Prev. Rehabil. 13: 180-185.
5. LEVENSON, J., P. GIRAL, M. RAZAVIAN, et al. 1995. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors. Arterioscler. Thromb. Vasc. Biol. 15: 1263-1268.
6. RIFAI, N. & P.M. RIDKER. 2001. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin. Chem. 47: 403-411.
7. LIO, D., G. CANDORE, A. CRIVELLO, et al. 2004. Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. J. Med. Genet. 41: 790-794.
8. LICASTRO, F., M. CHIAPPELLI, C.M. CALDARERA, et al. 2004. The concomitant presence of polymorphic alleles of interleukin-1beta, interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial infarction in elderly men. Results from a pilot study. Mech. Ageing Dev. 125: 575-579.
9. RIDKER, P.M. 1999. Evaluating novel cardiovascular risk factors: can we better predict heart attacks? Ann. Intern. Med. 130: 933-937.
10. RIDKER, P.M., N. RIFAI, M. PFEFFER, et al. 2000. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events aftermyocardial infarction. Circulation 101: 2149-2153.
11. JENNY, N.S., R.P. TRACY, M.S. OGG, et al. 2002. In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 22: 2066-2071.
12. RAY, K.K., N.J. CAMP, C.E. BENNETT, et al. 2002. Genetic variation at the interleukin-1 locus is a determinant of changes in soluble endothelial factors in patients with acute coronary syndromes. Clin. Sci. (Lond.) 103: 303-310.
13. CHIAPPELLI, M., C. TAMPIERI, E. TUMINI, et al. 2005. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Int. J. Immunogenet. 32: 349-353.
14. MIYATA, M. & J.D. SMITH. 1996. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat. Genet. 14: 55-61.
15. UTERMANN, G., A. HARDEWIG & F. ZIMMER. 1984. Apolipoprotein E phenotypes in patients with myocardial infarction. Hum. Genet. 65: 237-241.
16. LENZEN, H.J., G. ASSMANN, R. BUCHWALSKY & H. SCHULTE. 1986. Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease. Clin. Chem. 32: 778-781.
17. EICHNER, J.E., L.H. KULLER, T.J. ORCHARD, et al. 1993. Relation of apolipoprotein E phenotype tomyocardial infarction and mortality from coronary artery disease. Am. J. Cardiol. 71: 160-165.
18. LEHTINEN, S., T. LEHTIMAKI, T. SISTO, et al. 1995. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. Atherosclerosis 114: 83-91.
19. SCAGLIONE, L., S. BERGERONE, R. GAMBINO, et al. 1999. Role of lipid, apolipoprotein levels and apolipoprotein E genotype in young Italian patients with myocardial infarction. Nutr. Metab. Cardiovasc. Dis. 9: 118-124.
20. HUMPHRIES, S.E., L.A. LUONG, M.S. OGG, et al. 2001. The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur. Heart J. 22: 2243-2252.
21. ANDREOTTI, F., I. PORTO, F. CREA & A. MASERI. 2002. Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart 87: 107-112.
22. MORGAN, K., F. LICASTRO, L. TILLEY, et al. 2001. Polymorphism in the alpha(1)-antichymotrypsin (ACT) gene promoter: effect on expression in transfected glial and liver cell lines and plasma ACT concentrations. Hum. Genet. 109: 303-310.
23. CATALDO, F., D. LIO, V. MARINO, et al.; GROUPS OF THE SIGEP AND "CLUB DEL TENUE". 2003. Cytokine genotyping (TNF and IL-10) in patients with celiac disease and selective IgA deficiency. Am. J. Gastroenterol. 98: 850-856.
24. LIO, D., L. SCOLA, A. CRIVELLO, et al. 2002. Allele frequencies of +874T - > A single nucleotide polymorphism at the first intron of interferon-gamma gene in a group of Italian centenarians. Exp. Gerontol. 37: 315-319.
25. LICASTRO, F., L.M. GRIMALDI, M. BONAFE, et al. 2003. Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain. Neurobiol. Aging 24: 921-926.
26. WOODBURY, M.A. & J. CLIVE. 1974. Clinical pure types as a fuzzy partition. J. Cybernetics 4: 111-121.
27. WOODBURY, M.A., J. CLIVE & A. GARSON. 1978. Mathematical typology: a grade of membership technique for obtaining disease definition. Comput. Biomed. Res. 11: 277-298.
28. WOODBURY, M.A., K.G. MANTON & D.H. TOLLEY. 1994. A general model for statistical analysis using fuzzy sets: sufficient conditions for identifiability and statistical properties. Information Sciences 1: 149-180.
29. CORDER, E.H., M.A. WOODBURY, I. VOLKMANN, et al. 2000. Density profiles of Alzheimer disease regional brain pathology for the Huddinge Brain Bank: pattern recognition emulates and expands upon Braak staging. Exp. Gerontol. 35: 851-864.
30. CORDER, E.H., M.A. WOODBURY & L.L. FIELD. 2001. Grade-of-membership sibpair linkage analysis maps the IDDM11 locus to chromosome 14q24.3-q31: a pattern recognition approach to linkage. Ann. Hum. Genet. 65: 387-394.
31. IIVONEN, S., E. CORDER, M. LEHTOVIRTA, et al. 2004. Polymorphisms in the CYP19 gene confer increased risk for Alzheimer's disease. Neurology 62: 1170-1176.
32. HELISALMI, S., M. HILTUNEN, S. VEPSÄLÄ INEN, et al. 2004. Genetic variation in apolipoprotein D and Alzheimer's disease. J. Neurol. 251: 951-957.
33. HALLMAYER, J.F., L. KALAYDJIEVA, J. BADCOCK, et al. 2005. Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit. Am. J. Hum. Genet. 77: 468-476.
34. CORDER, E.H., J.F. ERVIN, E. FALLS, et al. 2005. Cardiovascular damage in Alzheimer Disease: autopsy findings from the Bryan ADRC. J. Biomed. Biotechnol. 2005: 189-197.
35. LI, Y.-Y., E.H. CORDER & L.S. CORDER. 2005. Disability patterns for U.S. elderly nursing home residents over two decades: findings from the 1973 to 1997 National Nursing Home Surveys. In Longer Life and Healthy Aging. Z. Yi, E. Crimmins, Y. Carriere & J.-M. Robine, Eds.: 35-47. Kluwer Academic Publishers. Boston, MA.
36. CORDER, E.H., R. HUANG, H.M. CATHCART, et al. 2006. Membership in genetic groups predicts Alzheimer's disease. Rejuvenation Res. 9: 89-93.
37. CORDER, E.H. & L.A. HEFLER. 2006. Multilocus genotypes spanning estrogen metabolism associated with breast cancer and fibroadenoma. Rejuvenation Res. 9: 56-60.
38. CORDER, E.H. & G.D. MELLICK. 2006. Parkinson's disease in relation to pesticide exposure and nuclear encoded mitochondrial complex I gene variants. J. Biomed. Biotechnol. 2006: 27601.
39. LICASTRO, F., E. PORCELLINI, C. CARUSO, et al. 2006. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and gene variants that up-regulate inflammation. Neurobiol. Aging 2006 Aug 21; [Epub ahead of print].
40. CORDER, E.H. & H. BEAUMONT. 2006. Susceptibility groups for Alzheimer's disease (OPTIMA cohort): integration of gene variants and biochemical factors. Mech. Ageing Dev. 2006 Nov 18; [Epub ahead of print].
41. TOLLEY, H.D. & K.G. MANTON. 1992. Large sample properties of estimates of discrete Grade of Membership model. Ann. Stat. Math. 44: 85-95.
42. FRASER, A.M. & H. SWINNEY. 1986. Independent coordinates for strange attractors from mutual information. Phys. Rev. A 33: 1134-1140.
43. FRASER, A.M. 1989. Reconstructing attractors from scalar time series: a comparison of singular system and dedundancy criteria. Physica D 34: 391-404.
44. FRASER, A.M. 1989. Information and entropy in strange attractors. IEEE Transact. Informat. Theory 35: 245-262.
45. GERDES, L.U., C. GERDES & K. KERVINEN. 2000. The apolipoprotein epsilon4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction: a substudy of the Scandinavian simvastatin survival study. Circulation 101: 1366-1371.
46. CORDER, E.H., L. LANNFELT, M. VIITANEN, et al. 2005. Does apolipoprotein E polymorphism determine the survivability of vascular accidents at advanced ages? Implications for mortality differentials. In Longer Life and Healthy Aging. Z. Yi, E. Crimmins, Y. Carriere & J.-M. Robine, Eds.: 141-150. Kluwer Academic Publishers. Boston, MA.
47. NABEL, E.G. 2003. Cardiovascular disease. N. Engl. J. Med. 349: 60-72.
48. POLA, R., A. FLEX, E. GAETANI, et al. 2003. Synergistic effect of -174 G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke. Stroke 34: 881-885.
49. GIACCONI, R., C. CIPRIANO, F. ALBANESE, et al. 2004. The -174G/C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing. Exp. Gerontol. 39: 621-628.
50. NAUCK, M., B.R. WINKELMANN, M.M. HOFFMANN, et al. 2002. The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction. J. Mol. Med. 80: 507-513.
51. GEORGES, J.L., V. LOUKACI, O. POIRIER, et al. 2001. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Temoin de l'Infarctus du Myocarde. J. Mol. Med. 79: 300-305.
52. PODGOREANU, M.V., W.D. WHITE, R.W. MORRIS, et al.; PERIOPERATIVE GENETICS AND SAFETY OUTCOMES STUDY (PEGASUS) INVESTIGATIVE TEAM. 2006. Inflammatory gene polymorphisms and risk of postoperativemyocardial infarction after cardiac surgery. Circulation 114: I275-I281.
53. KOCH, W., A. KASTRATI, C. BOTTIGER, et al. 2001. Interleukin-10 and tumor necrosis factor gene polymorphism and risk of coronary artery disease and myocardial infarction. Atherosclerosis 159: 137-144.
54. BERNARD, V., X. PILLOIS, I. DUBUS, et al. 2003. The -308 G/A tumor necrosis factor-alpha gene dimorphism: a risk factor for unstable angina. Clin. Chem. Lab. Med. 41: 511-516.
55. PAPADIMITRIOU, C.S., H. STEIN & N.X. PAPACHARALAMPOUS. 1980. Presence of alpha1-antichymotrypsin and alpha1-antitrypsin in haematopoietic and lymphoid tissue cells as revealed by the immunoperoxidase method. Pathol. Res. Pract. 169: 287-297.
56. LICASTRO, F., M. CHIAPPELLI, L.M. GRIMALDI, et al. 2005. A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease. Neurobiol. Aging 26: 449-453.
57. YAMADA, M., N. SODEYAMA, Y. ITOH, et al. 1998. Association of alpha1-antichymotrypsin polymorphism with cerebralamyloid angiopathy. Ann. Neurol. 44: 129-131.
58. GARCÍA RODRÍGUEZ, L., C. VARAS-LORENZO, A. MAGUIRE & A. GONZÁLEZ-PÉREZ. 2004. Nonsteroidal antiinflammatory drugs and the risk ofmyocardial infarction in the general population. Circulation 109: 3000-3006.
59. GARCIA RODRIGUEZ, L.A. & A. GONZÁ LEZ-PÉREZ. 2005. Long-term use of nonsteroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population. BMC Med. 3: 17.
60. IN T' VELD, B.A., A. RUITENBERG, A. HOFMAN, et al. 2001. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N. Engl. J. Med. 345: 1515-1521.
61. CORNELIUS, C., J. FASTBOM, B. WINBLAD & M. VIITANEN. 2004. Aspirin, NSAIDs, risk of dementia, and influence of the apolipoprotein E epsilon 4 allele in an elderly population. Neuroepidemiology 23: 135-143.
62. VAN OIJEN, M., P.P. ARP, F.J. JONG, et al. 2006. Polymorphisms in the interleukin 6 and transforming growth factor beta1 gene and risk of dementia The Rotterdam Study. Neurosci. Lett. 402: 113-117.